Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/bs.acc.2018.02.005PMID 29655463
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.

  2017cited by this paper
• Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review

  2017cited by this paper
• Transcriptomics in kidney biopsy is an untapped resource for precision therapy in nephrology: a systematic review.

  2017cited by this paper
• Metabolomics for clinical use and research in chronic kidney disease

  2017cited by this paper
• Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.

  2017cited by this paper
• The link between phenotype and fatty acid metabolism in advanced chronic kidney disease

  2017cited by this paper
• Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.

  2017cited by this paper
• Combined Clinical Phenotype and Lipidomic Analysis Reveals the Impact of Chronic Kidney Disease on Lipid Metabolism.

  2017cited by this paper
• Chronic Kidney Disease

  2017cited by this paper
• Proteomic definitions of basement membrane composition in health and disease.

  2017cited by this paper
• Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine.

  2017cited by this paper
• Removal of uremic retention products by hemodialysis is coupled with indiscriminate loss of vital metabolites.

  2017cited by this paper
• A urinary proteome‐based classifier for the early detection of decline in glomerular filtration

  2016cited by this paper
• Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases

  2016cited by this paper
• Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression

  2016cited by this paper
• The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury.

  2016cited by this paper
• Metabolomic application in toxicity evaluation and toxicological biomarker identification of natural product.

  2016cited by this paper
• Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers

  2016cited by this paper
• Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

  2016cited by this paper
• An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure

  2016cited by this paper
• Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

  2016cited by this paper
• Metabolomic Signatures of Chronic Kidney Disease of Diverse Etiologies in the Rats and Humans.

  2016cited by this paper
• Lipidomics: new insight into kidney disease.

  2015cited by this paper
• Utility of the CKD273 peptide classifier in predicting chronic kidney disease progression.

  2015cited by this paper
• Urinary proteomics in chronic kidney disease: diagnosis and risk of progression beyond albuminuria

  2015cited by this paper
• Proteomic biomarkers in kidney disease: issues in development and implementation

  2015cited by this paper
• Multidimensional proteomics for cell biology

  2015cited by this paper
• Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis

  2015cited by this paper
• Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

  2015cited by this paper
• Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy

  2015cited by this paper
• Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression.

  2015cited by this paper
• Metabolomics in nephrotoxicity.

  2014cited by this paper
• Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.

  2014cited by this paper
• Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications.

  2014cited by this paper
• Metabolomics in dyslipidemia.

  2014cited by this paper
• The urinary proteome as correlate and predictor of renal function in a population study.

  2014cited by this paper
• UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.

  2014cited by this paper
• UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.

  2014cited by this paper
• Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy.

  2014cited by this paper
• Proteomics, transcriptomics and lipidomics of exosomes and ectosomes

  2013cited by this paper
• Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.

  2013cited by this paper
• Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling

  2013cited by this paper
• CKD273, a New Proteomics Classifier Assessing CKD and Its Prognosis

  2013cited by this paper
• Metabolomics in chronic kidney disease.

  2013cited by this paper
• Intrarenal metabolomic investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E).

  2013cited by this paper
• Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.

  2013cited by this paper
• A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

  2013cited by this paper
• Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

  2012cited by this paper
• Urinary proteome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with magnetic beads for identifying the pathologic presentation of clinical early IgA nephropathy.

  2012cited by this paper
• Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS.

  2012cited by this paper
• Insights into the regulation of protein abundance from proteomic and transcriptomic analyses

  2012cited by this paper
• Effect of ergosta-4,6,8(14),22-tetraen-3-one (ergone) on adenine-induced chronic renal failure rat: a serum metabonomic study based on ultra performance liquid chromatography/high-sensitivity mass spectrometry coupled with MassLynx i-FIT algorithm.

  2012cited by this paper
• A comparison between MALDI-MS and CE-MS data for biomarker assessment in chronic kidney diseases.

  2012cited by this paper
• Evaluation of the Zucker Diabetic Fatty (ZDF) Rat as a Model for Human Disease Based on Urinary Peptidomic Profiles

  2012cited by this paper
• Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy

  2011cited by this paper
• Liver diseases

  2011cited by this paper
• Human urinary peptide database for multiple disease biomarker discovery

  2011cited by this paper
• Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment.

  2011cited by this paper
• Biomarkers in chronic kidney disease: a review.

  2011cited by this paper
• Kidney Injury Molecule-1 Outperforms Traditional Biomarkers of Kidney Injury in Multi-site Preclinical Biomarker Qualification Studies

  2010cited by this paper
• Proteomic Signatures in Plasma during Early Acute Renal Allograft Rejection*

  2010cited by this paper
• Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection.

  2010cited by this paper
• Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

  2010cited by this paper
• A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function

  2010cited by this paper
• Shotgun proteomics identifies proteins specific for acute renal transplant rejection

  2010cited by this paper
• Clustered O-Glycans of IgA1

  2010cited by this paper
• Proteomics in extracorporeal blood purification and peritoneal dialysis.

  2010cited by this paper
• Proteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children.

  2010cited by this paper
• Systems biology: opening new avenues in clinical research.

  2010cited by this paper
• Aptamer-based multiplexed proteomic technology for biomarker discovery

  2010cited by this paper
• Proteomic profiling of immunoglobulin A nephropathy in serum using magnetic bead based sample fractionation and matrix-assisted laser desorption/ionization-time of flight mass spectrometry.

  2010cited by this paper
• Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

  2010cited by this paper
• Proteomics database in chronic kidney disease.

  2010cited by this paper
• Systems biology to battle vascular disease.

  2010cited by this paper
• Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease*

  2010cited by this paper
• Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy

  2010cited by this paper
• Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury

  2010cited by this paper
• Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury

  2010cited by this paper
• Research at the interface of industry, academia and regulatory science

  2010cited by this paper
• A roadmap for biomarker qualification

  2010cited by this paper
• Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

  2009cited by this paper
• Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease.

  2009cited by this paper
• Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney Disease

  2009cited by this paper
• Aberrant protein expression in plasma and kidney tissue during experimental obstructive nephropathy

  2009cited by this paper
• 2nd Combined Working Group and Management Committee Meeting of Urine and Kidney Proteomics COST Action 29–30 March 2009, Nafplio, Greece

  2009cited by this paper
• Identification of urinary soluble E‐cadherin as a novel biomarker for diabetic nephropathy

  2009cited by this paper
• A further investigation on a MALDI-based method for evaluation of markers of renal damage.

  2009cited by this paper
• Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease.

  2009cited by this paper
• Bioinformatics analysis of mass spectrometry‐based proteomics data sets

  2009cited by this paper
• The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease

  2009cited by this paper
• Low molecular weight proteins in urines from healthy subjects as well as diabetic, nephropathic and diabetic-nephropathic patients: a MALDI study.

  2009cited by this paper
• Comprehensive analysis of short peptides in sera from patients with IgA nephropathy.

  2009cited by this paper
• KEGG for representation and analysis of molecular networks involving diseases and drugs

  2009cited by this paper
• Mass spectrometry-based proteomic analysis of urine in acute kidney injury following cardiopulmonary bypass: a nested case-control study.

  2009cited by this paper
• Increased urinary excretion of orosomucoid is a risk predictor of diabetic nephropathy

  2009cited by this paper
• The urinary proteome in diabetes and diabetes‐associated complications: New ways to assess disease progression and evaluate therapy

  2008cited by this paper
• Proteomic analysis of early urinary biomarkers of renal changes in type 2 diabetic patients

  2008cited by this paper
• Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics.

  2008cited by this paper
• The Universal Protein Resource (UniProt) 2009

  2008cited by this paper
• Urine protein profile of IgA nephropathy patients may predict the response to ACE‐inhibitor therapy

  2008cited by this paper

• Identification and validation of an explainable early-stage chronic kidney disease prediction model: a multicenter retrospective study

  2025cites this paper
• Proteomic Analysis of Circulating IgA1-Containing Immune Complexes in Patients with IgA Nephropathy

  2025cites this paper
• A Mini Review: Role of Novel Biomarker for Kidney Disease of Future Study

  2025cites this paper
• Emerging roles of exosomes in the diagnosis and treatment of kidney diseases

  2025cites this paper
• Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine

  2024cites this paper
• Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential

  2024cites this paper
• The potential protective effect of Rosuvastatin and chrysin combination against hepatic fibrosis induced by ethanol

  2024cites this paper
• Constructing and Validating a Network of Potential Olfactory Sheathing Cell Transplants Regulating Spinal Cord Injury Progression

  2023cites this paper
• Biomarker-Development Proteomics in Kidney Transplantation: An Updated Review

  2023cites this paper
• Alterations in the Circulating Proteome Associated with Albuminuria

  2023cites this paper
• Urinary peptidome analysis in CKD and IgA nephropathy

  2023cites this paper
• Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis

  2022cites this paper
• Urine protein in patients with type I hypersensitivity is indicative of reversible renal tube injury.

  2022cites this paper
• Clinical applications of plasma proteomics and peptidomics: Towards precision medicine

  2022cites this paper
• GEMminer: TEXT MINING TOOL FOR GENOME-SCALE METABOLIC MODEL

  2022cites this paper
• Identifying hub genes and miRNAs in Crohn’s disease by bioinformatics analysis

  2022cites this paper
• Application of peptide biomarkers in life analysis based on liquid chromatography–mass spectrometry technology

  2022cites this paper
• Integrated metabolomics coupled with pattern recognition and pathway analysis to reveal molecular mechanism of cadmium-induced diabetic nephropathy.

  2021cites this paper
• Identification of Immune-Related Genes in Sepsis due to Community-Acquired Pneumonia

  2021cites this paper
• Discovery of NEU1 as a candidate renal biomarker for proliferative lupus nephritis chronicity

  2021cites this paper
• Urinary Proteomics Identifying Novel Biomarkers for the Diagnosis and Phenotyping of Carotid Artery Stenosis

  2021cites this paper
• Diagnostic value of phosphatidylethanolamine binding protein 4 levels in patients receiving nursing interventions for advanced chronic kidney disease

  2021cites this paper
• Unmasking the Therapeutic Potential of Biomarkers in Type-1 Diabetes Mellitus

  2021cites this paper
• The association between plasma proteomics and incident cardiovascular disease identifies MMP-12 as a promising cardiovascular risk marker in patients with chronic kidney disease.

  2020cites this paper
• Proteomic analysis of rat kidney under maleic acid treatment by SWATH-MS technology.

  2020cites this paper
• Use of urinary proteomics in diagnosis and monitoring of diabetic kidney disease.

  2020cites this paper
• Application and Research Progress of Proteomics in Chicken Meat Quality and Identification: A Review

  2020cites this paper
• Bioinformatics-Based Study to Investigate Potential Differentially Expressed Genes and miRNAs in Pediatric Sepsis

  2020cites this paper
• Altered Phosphorylation of Cytoskeleton Proteins in Peripheral Blood Mononuclear Cells Characterizes Chronic Antibody-Mediated Rejection in Kidney Transplantation

  2020cites this paper
• Loganin alleviates macrophage infiltration and activation by inhibiting the MCP-1/CCR2 axis in diabetic nephropathy.

  2020cites this paper
• Computational Advances in the Label-free Quantification of Cancer Proteomics Data.

  2019cites this paper
• Urinary Peptidomic Biomarkers in Kidney Diseases

  2019cites this paper
• Nephrology: fundamental and clinical

  2019cites this paper
• Chronic kidney disease: Biomarker diagnosis to therapeutic targets.

  2019cites this paper
• Early detection of unilateral ureteral obstruction by desorption electrospray ionization mass spectrometry

  2019cites this paper
• Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.

  2019cites this paper
• Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis

  2019cites this paper
• AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways

  2019cites this paper
• TMT‐Based Proteomics Profiling of Bovine Liver Underscores Protein Markers of Anabolic Treatments

  2019cites this paper
• Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo

  2019cites this paper
• Deletion of Dicer blocks osteogenic differentiation via the inhibition of Wnt signalling.

  2019cites this paper
• NMR and MS urinary metabolic phenotyping in kidney diseases is fit-for-purpose in the presence of a protease inhibitor.

  2019cites this paper
• The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.

  2018cites this paper
• Natural products for the prevention and treatment of kidney disease.

  2018cites this paper
• Yinchenhao Decoction Alleviates Liver Fibrosis by Regulating Bile Acid Metabolism and TGF-β/Smad/ERK Signalling Pathway

  2018cites this paper
• Validation of a Novel Modified Aptamer-Based Array Proteomic Platform in Patients with End-Stage Renal Disease

  2018cites this paper
• New insights into TGF-β/Smad signaling in tissue fibrosis.

  2018cites this paper
• A blockade of PI3Kγ signaling effectively mitigates angiotensin II-induced renal injury and fibrosis in a mouse model

  2018cites this paper
• Silence of IGFBP7 suppresses apoptosis and epithelial mesenchymal transformation of high glucose induced-podocytes

  2018influential citation